Find Federal Grants
Loyalty and Reward-Based Technologies to Increase Adherence to Substance Use Disorder Pharmacotherapies (R41/R42 - Clinical Trial Optional)
National Institutes of Health · RFA-DA-19-015
Primary Caregiver Technical Assistance Supplements (PCTAS) (Clinical Trial Optional Admin Supp)
National Institutes of Health · PA-18-926
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimers Dementia (R21 Clinical Trial Optional)
National Institutes of Health · RFA-MH-19-511
Limited Competition for the Continuation of the Childhood Liver Disease Research Network (ChiLDReN) Scientific and Data Coordinating Center (U24 Clinical Trial Optional)
National Institutes of Health · RFA-DK-18-502
Limited Competition for the Continuation of the Childhood Liver Disease Research Network (ChiLDReN) Clinical Centers (U01 Clinical Trial Required)
National Institutes of Health · RFA-DK-18-501
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimers Dementia (R01 Clinical Trial Optional)
National Institutes of Health · RFA-MH-19-510
Identification, Surveillance, and Control of Vector-Borne and Zoonotic Infectious Diseases in Uganda
Centers for Disease Control and Prevention - ERA · RFA-CK-19-001
Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)
National Institutes of Health · PAR-18-923
Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R34 Clinical Trial Required)
National Institutes of Health · PAR-18-924
Expanding Access to Evidence-Based Voluntary Drug Demand Reduction Program in the Philippines
Philippines USAID-Manila · 72049218APS00001-04
National Institutes of Health · RFA-CA-19-002
Cancer Prevention Clinical Trials Network (CP-CTNet): Data Management, Auditing, and Coordinating Center (DMACC) (U24 Clinical Trials Required)
National Institutes of Health · RFA-CA-18-030
Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required)
National Institutes of Health · RFA-CA-18-029
Limited Competition for the Continuation of the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Data Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DK-18-511
Limited Competition for the Continuation of the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Research Sites (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DK-18-510
Limited Competition for the Continuation of the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Tissue and Technology Core (TATC) (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DK-18-515
Competitive Cooperative Agreement Solicitation Combating Opioid Overdose through Community-Level Intervention
Office of National Drug Control Policy · 2018-ONDCP-COOCLI
Limited Competition for the Continuation of the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Data Coordinating Core (DCC) (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DK-18-514
Limited Competition for the Continuation of the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Discovery Sites (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DK-18-513
Combination Prevention Solutions to Reach Epidemic Control among High Risk, Priority Populations in High Burden Areas in the Republic of South Africa under the President's Emergency Plan for AIDS Relief (PEPFAR)
Centers for Disease Control - CGH · CDC-RFA-GH19-1922